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doi:10.1
1076Background: The study purpose is to evaluate the long-term outcome of the in situ pericardial extracardiac lat-
eral tunnel Fontan operation.
Methods: From June 1994 to August 2009, 160 patients with single ventricle (boys, n ¼ 96, 60%, median
age¼ 39months, mean weight 15.5 kg) underwent the pedicled pericardial extracardiac lateral tunnel operation.
Patients’ charts were reviewed for perioperative and long-term follow-up data, outcome, and mortality. The po-
tential growth of these tunnels was evaluated.
Results: The main diagnoses included tricuspid atresia (n ¼ 44, 27%); double-outlet right ventricle (n ¼ 29,
18%), and hypoplastic left heart syndrome (n ¼ 26, 16%). The mean follow-up was 6.5  3.7 years (range:
0.1–15 years). There were 2 (1.3%) operative and 6 (3.7%) late deaths. Actuarial survival at 14 years was
93%. Early complications included prolonged effusions (n ¼ 35, 22%), chylothorax (n ¼ 5, 3.1%), readmis-
sions (n ¼ 35, 22%), cerebrovascular accidents (n ¼ 8, 5%), contralateral phrenic nerve palsy (n ¼ 1, 0.8%),
and transient arrhythmias (n¼ 5, 3.1%). No pacemaker was needed. Late complications included tunnel steno-
sis (n ¼ 3, 1.8%) managed with balloon dilatation and stenting in 2 patients and surgical revision in 1; tunnel
thrombosis (n¼ 2, 1.2%) causing death in both patients; and protein losing-enteropathy (n¼ 4, 2.5%). Follow-
up echocardiography of 10 patients showed laminar flow, no turbulence/gradient at the inferior vena cava and
mid-tunnel levels. The diameter indexed to body surface area showed growth, reduction, or no change depending
on flow demands.
Conclusions: The construction of the extracardiac lateral tunnel Fontan conduit using viable pedicled pericar-
dium is a relatively simple, durable, and safe operation. Long-term follow-up confirms low morbidity and
mortality. Fenestration is unnecessary in most patients. This viable tunnel adapts to physiologic flow demands.
(J Thorac Cardiovasc Surg 2010;140:1076-83)Since the introduction of the Fontan operation in 1971, dra-
matic improvements in the management of children with
single ventricle physiology have occurred.1 The separation
of the systemic and pulmonary circulations brought oxygen
saturation and the volume work of the systemic ventricle to
near normal in those patients. The long-term outcomes of
this initial palliative operation were not ideal. Accordingly,
several modifications to the original atriopulmonary con-
nection were introduced in an attempt to decrease postoper-
ative morbidity.2-4
The ‘‘cavopulmonary anastomosis,’’ also known as the
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The Journal of Thoracic and Cardiovascular Surtion, was introduced by de Leval and colleagues.5 This
modification provided more efficient and laminar flow,
but it also required cardiac arrest, intracardiac manipula-
tion, and atrial incisions. In 1988, extracardiac prosthetic
conduits were introduced in an attempt to decrease the inci-
dence of late atrial arrhythmias.6,7 The construction of the
cavopulmonary conduit extracardially has decreased the
cardiopulmonary bypass time, minimized myocardial is-
chemia, and resulted in better preservation of ventricular
and pulmonary vascular function, lower Fontan circuit
pressure, lower postoperative morbidity, and lower inci-
dence of atrial arrhythmias.8-10 The disadvantages of
these prosthetic conduits revolve largely around the pote-
ntial for thromboembolism, associated infection, lack of
growth potential in length and width, and a fixed (or even
decreased) luminal conduit diameter over time.11,12
Our initial report13 in 1997 reintroduced the use of a pedi-
cled pericardial tube first reported byHvass and colleagues14
in 1992. This technique constructs an extracardiac lateral
tunnel (ECLT) and completes the cavopulmonary connec-
tion. This report provides the long-term outcomes of the in
situ ECLT for the Fontan operation.
Although both intracardiac lateral tunnel conduits and
ECLT conduits are widely accepted as standard ‘‘Fontan’’gery c November 2010
Abbreviations and Acronyms
ECLT ¼ extracardiac lateral tunnel
IVC ¼ inferior vena cava
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may offer a better late outcome, cost benefit, and potential
for growth. The objective of our study was to assess perio-
perative and late results using this technique.C
H
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Study Population
Between June 1994 and August 2009 the medical records of all patients
undergoing a Fontan operation at Loma LindaUniversity ChildrenHospital
were reviewed. Starting in 2000, all data were collected prospectively, cre-
ating a database for all these patients. Only patients who had ECLT were
reviewed for this study. The Institutional Review Board of the Loma Linda
University approved the study. Of 183 patients who underwent total cavo-
pulomonary connection, 160 children underwent the completion Fontan
operation, using the autologous in situ pedicled pericardial ECLT. There
were 96 (60%) boys and 64 (40%) girls. The median age at operation
was 39 months (range, 1.5–15 years) with 72 (45%) patients younger
than 24 months. The median patient weight was 15.5 kg (range, 5–70
kg). The median pulmonary artery pressure was 12 mm Hg (range, 5–
19). The mean pulmonary resistance was 1.76 0.75 Wood units. The me-
dian preoperative oxygen saturation was 84% (range, 60%–89%).
Twenty-three patients who had other conduits used were excluded from
the study. In these patients other conduits were used if the pericardium
was not adequate to construct the tunnel, if the pericardium was stuck to
the lung, or if hepatic veins were not confluent and were too far apart.
The primary anatomic diagnoses are shown in Table 1. Twenty (13%) pa-
tients had heterotaxy and 18 (11%) had dextrocardia or mesocardia with
midline inferior vena cava (IVC). All patients underwent prior procedures,
which include bidirectional Glenn anastomosis (n ¼ 157, 98.1%), Kawa-
shima operation (n ¼ 3, 1.9%) systemic–pulmonary artery shunt
(n ¼ 78, 48.8%), Norwood operation (n ¼ 38, 23.8%), pulmonary artery
band (n ¼ 26, 16%), open atrial septectomy with Fontan operation
(n ¼ 9,5.6%) and Damus–Kay–Stansel procedure (n ¼ 9, 5.6%).
Aortic crossclamping was used in 29 (18%) patients only to complete
additional procedures. These include atrial septectomy, pulmonary angio-
plasty, and valve repair.
Early or perioperative complications/mortality were defined as those oc-
curring within 30 days of the operation. This included readmission, reop-
eration for bleeding, prolonged intubation (>48 hours), the need for
reoperation or reintervention, or prolonged chest tube drainage (>14 days).TABLE 1. Anatomic primary diagnoses
Diagnosis n (%)
Tricuspid atresia 44 (27)
Double-outlet right ventricle 29 (18)
HLHS 26 (16)
Double-inlet left ventricle 20 (13)
Pulmonary atresia/IVS 16 (10)
Unbalanced AVC 14 (9)
Other CHD 11 (7)
HLHS, Hypoplastic left heart syndrome; IVS, intact ventricular septum; AVC, atrio-
ventricular canal; CHD, congenital heart disease.
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Preparations for this operation begin with the initial 1 or 2 operations in
this multistaged procedure by preserving and minimizing unnecessary dis-
section of the right pericardium. All operations were performed through
redo median sternotomy, using cardiopulmonary bypass and deep hypo-
thermia that allows low flow and better exposure. The surgical technique
was similar to that described in our initial report.13 The technique is de-
picted in Figure 1, A to C. We no longer suture between the pulmonary
veins to obliterate severe ‘‘valleys.’’ This posterior floor obliterates sponta-
neously and becomes smooth with time. In 10 (6.3%) patients the superior
part of the pericardium was deficient. To avoid a narrow conduit, we used
a small piece of contralateral pericardium (n ¼ 6, 3.8%) or supple bovine
pericardium (n¼ 4, 2.5%) to make up for the deficiency. Fenestration was
selectively performed (n ¼ 4, 2.5%) when the conduit pressure was ele-
vated (>18mmHg) or when preoperative hemodynamics were suboptimal.
All patients were weaned from cardiopulmonary bypass on low-dose ni-
troglycerin (0.25–0.5 mg $ kg1 $min1) with or without dopamine (3–5 mg
$ kg1 $ min1). Postoperative management goals were early extubation,
placement on a regimen of angiotensin-converting enzyme inhibitors, di-
uretics, and aspirin, and chest tube retention until drainage was less than
100 mL per day. All patients were discharged home receiving aspirin at
10 mg/kg or 81 mg daily for bigger children.
To assess the tunnel growth in 10 patients who had complete echocardi-
ography data, we evaluated the tunnel diameter proximally at the IVC–
atrium junction and in the mid zone of the tunnel to assess adaptation of
these tunnels to the physiologic flow demands. These measurements
were indexed to the body surface area at the time of the measurement.
Data Analysis
Datawere collected initially by retrospective review of the patient’s hos-
pital records and later (after 2000) prospectively. Data were expressed as
mean  standard deviation and median (range) for continuous variables.
The primary outcome variable in this study was survival with an intact Fon-
tan circulation. Failurewas defined as death or takedown of the Fontan con-
nection or as early failure if death or takedown occurred within 30 days
from surgery. Secondary end points were arrhythmias or delayed Fontan
tunnel complications requiring in interventional procedures. Survival
data and probability of freedom from time-related events were analyzed
by the method of Kaplan and Meier.RESULTS
Postoperative Complications
No inotropic support was used in 73 (46%) patients.
Postoperative mean oxygen saturation was 93%  4.8%
(range, 70%–98%). Postoperative mean central venous
pressure was 14 mm Hg (range, 11–20 mm Hg).
Among those 160 patients, 107 (67%) were extubated in
the operating room, 16 (10%) within 6 hours of surgery, and
25 (16%) were extubated within the first 24 hours. Only 12
(7.5%) patients required more than 24 hours of intubation.
Before 2002, 21 of 48 (44%) patients were extubated in the
operating room compared with 86 of 112 (77%) patients af-
ter 2002.
The mean hospital stay was 4.2  0.6 days (range, 1–66
days). The mean follow-up was 6.5 5.3 years (range, 0.1–
15 years). Five patients were lost to follow-up.
A total of 8 (5%) deaths occurred over 15 years. Two
(1.25%) were within 30 days of surgery and 6 (3.8%)
were late deaths (Table 2). In the last 9 years there werediovascular Surgery c Volume 140, Number 5 1077
FIGURE 1. A to C, Surgical technique. ECLT, Extracardiac lateral tunnel; RA, right atrium.
TABLE 2. Mortality cases
Patient
Age/year at
ECLT Fontan
Time to
death Cause of death
1 19 mo/1994 22 d HF, MSOF, tunnel
thrombosis
2 4.5 y/1995 3 mo IC hemorrhage
3 16 mo/1996 45 d HF, sepsis
4 2 y/1996 3 y IC hemorrhage, AV malformation
5 17 y/1997 1 y Tunnel thrombosis, MSOF, sepsis
6 7 y/2000 2 y HF, AVVR
7 2 y/2005 3 d Malignant hyperthermia,
shock, MSOF
8 2 y/2008 12 mo HF
ECLT, Extracardiac lateral tunnel; HF, heart failure; MSOF, multisystem organ fail-
ure, IC, intracranial; AV, arteriovenous; AVVR, atrioventricular valve regurgitation.
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Donly 2 (1.25%) deaths. The actuarial survival at 14 years
was 93% (Figure 2).
Postoperative bleeding complications occurred in 7
(4.4%) patients. Six required reoperation for bleeding
(n ¼ 6, 3.8%) and 1 had tamponade. One patient required
takedown of the Fontan conduit and conversion to the bidi-
rectional Glenn operation owing to hemodynamic failure.
One patient had phrenic nerve injury on the contralateral
side of the ECLT Fontan conduit.
Pleural effusion was the main cause of readmissions
(n¼ 25) and repeated hospital/clinic visits. Prolonged pleu-
ral effusion (>14 days) occurred in 36 (22%) patients and
chylothorax in 5 (3.1%). One required thoracic duct liga-
tion and 4 were treated successfully with medical treatment.
The initial mean hospital stay of 4.2 days was not affected
by the tube drainage inasmuch as parents were trained to re-
cord output and report it to the treating surgeon in the clinic.
New transient arrhythmias occurred in 5 (3.1%) patients
(3 bradycardias and 2 tachycardias). All were treated med-
ically without the need for a pacemaker. All patients were
documented to remain in normal sinus rhythm with an ade-
quate rate at their long-term follow-up.
Stroke or neurologic deficit occurred in 8 (5%) patients.
Only 2 late-onset strokes were related to the procedure. One
happened 4 weeks after the Fontan operation and the patient
had a complete recovery. The second patient was admitted
with sepsis that was complicated by left middle cerebral ar-
tery infarction, multisystem organ failure, and death.
Tunnel complications occurred in 5 (3.1%) patients. Ste-
nosis owing to technical error occurred in 3 (1.9%) patients.
Two required balloon dilatation and stenting and 1 underwent
correction with surgical revision. All of them did well with-
out further complications. Thrombosis occurred in 2 (1.25%)
patients; both were admitted with sepsis that was compli-
cated by Fontan tunnel thrombosis, multisystem organ fail-
ure, and death. After 1997, tunnel stenosis happened in1078 The Journal of Thoracic and Cardiovascular Sur1 patient only and was treated successfully with balloon dila-
tation and stenting. Protein-losing enteropathy was encoun-
tered in 3 (1.9%) patients. All had tunnel complications.
Mild compression of the right pulmonary veins was reported
in 1 case but did not require any intervention. Themajority of
the cases were done in the recent era (2002–2009) (n¼ 112,
70%) compared with the early era (1994–2001) (n ¼ 48,
30%). The mortality, risk of thromboembolism, and the
use of other conduits were 2 (1.2%), 1 (0.6%), and 9
(39%) during the recent era compared with 6 (3.8%), 4
(2.8%), and 14 (61%) during the early era, respectively.
The initial proximal IVC–tunnel junction diameter in the
10 patients measured 18 to 24 mm compared with 19 to 30
mm at the mid-tunnel area. These measurements increased,
decreased, or stayed the same at both the IVC and mid-
tunnel over 3 years of follow-up (Figure 3). However,
when the diameters were indexed to the patient’s body sur-
face area, they remained unchanged at both the IVC end and
the mid-tunnel area—8 to 13 mm and 12 to 16 mm, respec-
tively. All uncomplicated tunnels showed laminar flow, no
turbulence, and no gradient at both ends of the tunnel.gery c November 2010
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ography. None of these tunnels showed calcification on ra-
diologic studies.
DISCUSSION
Since the inception of the Fontan operation in 1971,1 its
results have steadily improved.15 Improvements in surgical
technique in both extracardiac conduit and lateral tunnel
Fontan operations, advances in ICU care, patient selection,
and understanding of the physiology of the cavopulmonary
circulation in patients with single ventricle physiology have
resulted in decreased pleural effusions, shorter hospital
stays, and decreased morbidity and mortality.16 Neverthe-
less, survivors are still having arrhythmias, conduit stenosis,
infections, and thromboembolism.17-23 The modifications
to the original atriopulmonary connection procedure
resulted in improved outcome.5,24,25
The lateral intracardiac tunnel introduced by de Leval and
colleagues5 and its successful clinical application by the
Boston Children’s Group15 resulted in widespread accep-
tance of the technique. However, several drawbacks remain,
such as the need for cardiac arrest, atrial suture lines, and he-
modynamic and thromboembolic issues related to the intraa-
trial baffle. The ECLT techniquewas introduced in search of
a simpler operation with better hemodynamics,6-8 Although
the initial operation was described using cardioplegia,
cooling, and circulatory arrest,6 the operation has been sim-
plified and is presently performed by many with a short
period of cardiopulmonary bypass and by some without
bypass.13,26
The prosthetic material used in the classic ECLT Fontan
operation lacks growth potential and decreases in diameter
by 18% to 32% within the first 6 months.9 Homografts get
calcified with time and defeat its hemodynamic purpose.
Infection of these prosthetic conduits is rare but is a potential
concern.The Journal of Thoracic and CarThis procedure is simple and reproducible. Preserving
the pericardium and avoiding dissection in the right pericar-
dial area during the preceding staged operations provides
adequate pericardium to complete the tunnel in almost all
cases. Partial augmentation was used in a few cases using
contralateral pericardium or bovine pericardium to success-
fully complete the tunnel. Adachi and his colleagues27 were
able to reconstruct the conduit in only 28 of 202 patients
owing to lack of pericardium. This is because they used
a slightly different approach of a complete pericardial roll
that would require more pericardium than a flap, as in this
technique. This technique was feasible to use in patients
with dextrocardia or mesocardia with midline IVC. This
technique is versatile and can be adopted in most cases re-
gardless of the anatomic substrate.
Lemler and colleagues28 showed significant reduction in
chest tube drainage with fenestrations. Fenestration, on the
other hand, is associated with potential complications in-
cluding thromboembolic phenomena with neurologic se-
quelae.29,30 We rarely attempt fenestration and believe
that fenestration defeats the purpose of this operation of
maintaining near normal saturation. The ECLT, as seen in
other series, improves hemodynamics, hence making
fenestration unnecessary.31,32
The pericardium has been routinely used in surgery for
congenital cardiac disease as a graft substitute. The free sur-
face of the pericardium is neither immunogenic nor throm-
bogenic.12 Owing to lack of thrombogenicity, all patients in
this report were maintained on an aspirin regimen without
full anticoagulation with minimal risk of thromboembo-
lism. The risks of thromboembolism of 1.25% in this series
are comparable with the 2.5% to 25% rates reported after
different types of Fontan operations.20-22,29 Left-sided em-
boli (in the absence of fenestration) should be eliminated
in extracardiac tunnels inasmuch as no foreign material ex-
ists within the heart.
As a vascularized live pedicle, pericardial tissue should
theoretically grow with the heart and mediastinal structures
as it does normally. In our early report, we13 showed that au-
tologous viable pericardium has the potential for growth but
long-term follow-up was not available. The intrinsic adjust-
ability of the viable pericardial tunnel, which has the ability
to vary its own shape in response to the flow volume passing
through it relative to body size, was shown in this study
using echocardiography (Figure 3). Similar findings were
reported angiographically by Adachi and colleagues.27
Our echocardiographic and angiographic data showed no
evidence of narrowing, obstruction, or dilatation during the
follow-up period.
Arrhythmias and the need for a pacemaker were not
a concern in this series after long-term follow-up although
the tunnel was sutured to the outside of the right atrium. Al-
though it appears that sinus node dysfunction and arrhyth-
mias are potential risks with this technique, this was notdiovascular Surgery c Volume 140, Number 5 1079
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the atrial suture line was performed away from the sinus
node.
Although we had no phrenic nerve injury on the side of
the Fontan tunnel, it remains a major concern in this ap-
proach and carries an increased morbidity after Fontan op-
eration.33 Close attention to the phrenic nerve and its blood
supply while preparing the baffle is important to avoid in-
jury to the nerve.
The theoretical concern of right pulmonary vein compres-
sion has not manifested itself clinically in this study. The
concern of anterior compression of the right pulmonary
veins by the enlarged right atrium seen in the ‘‘classic’’ Fon-
tan procedure was not encountered in this series by either
echocardiography or angiography over long-term follow-up.
The overall survival in this series is 93% at 10 and 14
years, comparable with those reported by other techniques
(Table 3).TABLE 3. Ten-year survival after Fontan operation
No. of patients Years of operation Survival (%)
Fontan et al34 1990 334 1975–1988 69%
Driscoll et al35 1992 352 1973–1984 70%
Cetta et al36 1992 339 1987–1992 81%
Gentles et al15 1997 500 1973–1991 79%
Stamm et al37 2001 220 1987–1991 91%
Weipert et al23 2004 162 1978–1995 83%
Giannico et al38 2006 221 1988–2003 85%
Present study 2009 160 1994–2009 93%
1080 The Journal of Thoracic and Cardiovascular SurChowdhury and colleagues39 have shown in their small
series that this technique reduces arrhythmias, requires no
anticoagulation, and provides the potential for tunnel
growth.
The cost of a homograft in the United States is around
$7000 to $9000. The cost of the polytetrafluoroethylene
graft (Gore-Tex graft; W. L. Gore & Associates, Inc, Flag-
staff, Ariz) used to reconstruct the ECLT is around $400 to
$500. The pericardial conduit costs zero dollars. This adds
another advantage to this technique during this time when
cost is a major concern in health care.CONCLUSIONS
The construction of the ECLT Fontan conduit using via-
ble pedicled pericardium is a relatively simple, durable, and
safe operation. Long-term follow-up confirms low morbid-
ity and mortality. Fenestration is unnecessary in most pa-
tients. This viable tunnel adapts to physiologic flow
demands.References
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Dr Erle H. Austin III (Louisville, Ky). I have no disclosures.
I congratulate Dr Hasaniya on an excellent presentation and
thank him for providing me with the manuscript and slides to
help me prepare these comments. I also thank Dr Bailey and his
colleagues for introducing this technique back in the mid-1990s.
Although I am aware that Dr Hvass should be credited with the
pedicle pericardial tube concept, the Loma Linda group modified
the technique to use the atrial epicardium as the medial wall of the
extracardiac pathway and began to apply this technique to the vast
majority of their Fontan candidates.
Back in 1995, when the extracardiac conduit idea was begin-
ning to catch on, I began to convert to the polytetrafluoroethylene
tube technique. My enthusiasm for that approach, however, signif-
icantly waned when I almost lost a patient on the second postoper-
ative day when the polytetrafluoroethylene conduit acutely
thrombosed. After that unsettling experience, I was seriously con-
sidering reverting to the lateral tunnel when I heard Dr Steve Gun-
dry, who was Len Bailey’s associate at the time, describe this idea
of using the patient’s own viable vascularized in situ pericardium
to construct the Fontan pathway. As this seemed to me at the time
to be much less likely to pose a thrombosis risk, I soon tried the
approach myself, and it has been the technique I have used most
commonly ever since. My experience is somewhat more modest
in terms of numbers and length of follow-up, having reported
our 7-year experience back in 2004, but it has essentially matched
the excellent results that you have presented today. I am especially
pleased to see that your 10-year overall survival is as good as any
other reported series of Fontan operations. However, as suggested
in Sunday morning’s congenital symposium, we may need at leastdiovascular Surgery c Volume 140, Number 5 1081
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currently applied Fontan techniques proves to be the superior one.
Like you, with the extracardiac pedicle pericardial approach, I
have rarely found it necessary to perform fenestration in these pa-
tients. I have learned that in some cases it is necessary to augment
the pericardial flap with some bovine pericardium to avoid any nar-
rowing of the pathway, especially over the pulmonary veins. Un-
like you, however, I have not felt the need to cool substantially
on bypass and have thus usually been able to complete the con-
struction of the pathway in less than an hour of bypass time. The
excellent early postoperative course in your patients, however, sug-
gests that extra time on bypass had minimal if any adverse effect.
Despite what we consider to be enviable results, you did have
a few problems, specifically with the created extracardiac tunnel.
You indicated in the presentation and in the manuscript that 3 pa-
tients had pathway stenosis that was attributed to technical error. I
do think that this technique is slightly more technically demanding
than simply sewing in 2 ends of a tube graft and that may explain
why relatively few surgeons have tried this technique.
My first question, therefore, is this: Can you describe the tech-
nical errors that were encountered and what technical pitfalls your
mentors may have taught you to avoid when you perform this
novel technique?
Dr Hasaniya. Thank you, Dr Austin, for taking the time to re-
view our manuscript and thank you for your questions.
Of course, I joined the team at Loma Linda approximately 5
years ago, and so I avoided these pitfalls. There are a few important
points: We are operating close to the phrenic nerve, but it really is
not necessary to dissect close to the phrenic nerve, except some-
times inferiorly, and that must be done carefully to release the peri-
cardium. As I showed, we did not have any nerve injury on the side
of Fontan.
The other important point is not to make the tunnel really big. If
you need to trim the pericardium, you need to do so tomake the tun-
nel diameter equal or slightly bigger than the diameter of the IVC.
Most of these technical errors happened in our early experience;
they happened mainly in the IVC junction. However, we have not
experienced any of these in the last probably 7 to 9 years. This
could be attributed to Dr Bailey’s modification of suturing the peri-
cardial flap to the diaphragm (not to the IVC edge) to avoid steno-
sis at that anastomosis.
Dr Austin. In my own learning experience, the IVC area was
the area that was of greatest concern. I did find that if you are
not careful, you can create a twist in the pathway when you place
the clamp to oversew the atrial side of the IVC–atrial junction. If
you do not place the clamp in a straight anteroposterior orientation,
you can get a twist and narrowing at that particular point.
Dr Hasaniya. That is probably the advantage of hypothermia
because that allows us not to use any clamps on the IVC; we just
use a flexible sucker in the IVC and everything is wide open. We
usually match the medial part with a stay suture before we com-
plete the anterior anastomosis.
Dr Austin. My second question relates to fenestration. I know
that it was rarely performed in your experience, but you do need
to be prepared to perform it. If you find yourself in that situation,
how exactly would you perform it?
Dr Hasaniya. Intraoperatively, you can use a punch before
closing the tunnel into the side of the right atrial wall to create1082 The Journal of Thoracic and Cardiovascular Surthe fenestration. The advantage of this technique is you can do it
after surgery as well. This technique allows you to take the patient
to the cardiac catheterization laboratory and pass a guidewire
puncture through the right atrium and then create the fenestration.
Dr Austin. Did you ever do that?
Dr Hasaniya. Yes, we have done it in 1 patient.
Dr Austin. Just to add to your response, we had a patient in
whom protein-losing enteropathy developed within a year of this
operation. Echocardiography and catheterization showed a very
competent pathway, and so there was not a problem with the
tunnel. However, we were able to perforate the atrial wall in the
catheterization laboratory, creating a fenestration and actually im-
proving the protein-losing enteropathy, so that is an advantage to
this technique of extracardiac Fontan.
Finally, what are your current preferred age and weight criteria
for performing this operation? Since you have confirmed in at least
10 patients that the in situ pedicle extracardiac conduit grows with
the patient, do you think that it is necessary to wait for the patient
to reach a certain size before proceeding to the Fontan operation as
some surgeons do when placing a conduit that does not have
growth potential?
Dr Hasaniya. That is an excellent question. As you mentioned,
the growth potential has been documented also by other reports in
the literature. Because of that, in the past 7 or 8 years, we have per-
formed the Fontan operation around 2 years of age in most of our
patients, unless there is some other contraindication. If we do an
age analysis, the majority of the patients at present undergo the
Fontan operation around 2 years of age.
Dr Austin. Is there something special about 2 years, or is that
just because everybody else does it that way?
DrHasaniya. That is what we do. We do have a small subgroup
of children under age 2 (18–22 months) who had completion Fon-
tan with good outcomes. This technique allows for completion
Fontan at a younger age. In fact, a smaller sized child may be
advantageous and easier to treat with shorter cardiopulmonary by-
pass time, less time to cool, and shorter time to rewarm. Yes, this is
a definite advantage of the technique.
Dr Austin. Again, my congratulations to you and your coau-
thors for developing and sticking with this innovative approach
to the Fontan operation.
Dr James S. Tweddell (Milwaukee, Wis).You said in your con-
clusion that this technique adapts to flow dynamics. Can you ex-
pand on that a little bit? What did you mean precisely by that?
Dr Hasaniya. If you look at the diameter of the tunnel at the
IVC junction and the mid tunnel, when we measured that over 3
years, in some of these patients the diameter increased, some of
them stayed the same, and some of them became smaller. As
you know, when you create the tunnel it is done by eyeballing,
so the tunnel does either increase, decrease, or not change, depend-
ing on the flow demands. This is why when we index that to the
body surface area, we get a flat line.
Dr Tweddell. I see. And your hospital length of stay was laud-
ably short, 4.2 days. That is really fantastic, but about 20% of the
patients were readmitted. Did you look at that group of patients to
determine why they were readmitted?
DrHasaniya.We are in the process of studying these patients. I
know that in a few reported series, the hospital stay is usually
around 10 days or more. What we have been adopting in recentgery c November 2010
Hasaniya et al Congenital Heart Diseaseyears is to send these patients home with a Blake drain on the right
side, and we teach the parents to record the output daily. We ob-
serve them as outpatients until the drainage is low, and then we
take drain out as outpatients.
Dr Tweddell.What percentage of patients were sent home with
a drain in?
Dr Hasaniya. Nowadays, close to 100% are sent home with
a Blake drain in place.The Journal of Thoracic and CarDr Ayman Abdul-Ghani (Anniston, Ala). Congratulations on
your study. Why did you study only 10 patients for the growth
pattern?
DrHasaniya. The reasons were lack of time and lack of money.
We did not have money to pay the technician to really analyze
more than 10 patients. These patients had several echocardiograms
done. We selected whatever could be done by the technician and
we did the analysis on these 10 patients.diovascular Surgery c Volume 140, Number 5 1083
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